Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TX Providers

Dr. Virginia Kaklamani, MD

Accepting New Patients

(296 Ratings)

Specializes in: Medical Oncology, Adult Oncology and Hematology (Blood Disorders)

University of Athens Faculty of Medicine

Professional interests include: anemia

4502 Medical Drive
San Antonio, TX 78229

(210) 358-4000

Dr. Virginia Kaklamani, MD is a medical oncologist in San Antonio, TX specializing in medical oncology, adult oncology and hematology (blood disorders). She graduated from University of Athens Faculty of Medicine. Dr. Virginia Kaklamani, MD is affiliated with Baptist Health System, University Health, Baptist Hospital and UT Health San Antonio.

Office Locations

Address:

4502 Medical Drive
San Antonio, TX 78229

Address:

7979 Wurzbach Road
San Antonio, TX 78229

Some issues Dr. Virginia Kaklamani, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

In The News (see more mentions in the news)

“"This is an option that patients should consider for their DCIS," said Dr. Virginia Kaklamani of the University of Texas Health Science Center San Antonio, who was not involved in the research.”—"Some breast cancer patients can avoid certain surgeries, studies suggest", Dayton Daily News, December 2024

“Dr. Virginia Kaklamani, breast medical oncologist and professor of medicine, UT Health San Antonio, MD Anderson Cancer Center, commented, "Elacestrant is a potential exciting new endocrine therapy...”—"Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting", Associated Press News, June 2022

“Dr. Virginia Kaklamani, clinical researcher at UT Health San Antonio, joined a panel during a training session at the Menger Hotel in San Antonio last year that held at the same time as the San...”—"Coronavirus forces San Antonio's annual breast cancer meeting to go virtual", San Antonio Express-News, September 2020

biological response modifier (BRM) therapy	155
blood draw	44
chemotherapy	155
doctor visit	426
hormone therapy	41
hospital care	54
inpatient care	54
lab tests	131
minimally invasive procedures	187

**Gender**
Male	38
Female	362

**Ethnicity**
Non-Hispanic White	253
Black	97
Hispanic	34
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	229
From 75 to 84	82
85 and over	26
Less than 65	63

Hypertension	59
High Cholesterol	39
Stroke	5
Ischemic Heart Disease	21
Depression	15
Chronic Kidney Disease	22
Asthma	9
Osteoperosis	10
Atrial Fibrilation	6
Heart Failure	11
Chronic Obstructive Pulmonary Disease	7
Diabetes	23
Dementia	4
Cancer	75

biological response modifier (BRM) therapy	128
blood draw	116
chemotherapy	128
doctor visit	447
hormone therapy	61
hospital care	133
inpatient care	133
lab tests	273
minimally invasive procedures	181

**Gender**
Male	53
Female	364

**Ethnicity**
Non-Hispanic White	272
Black	80
Hispanic	43
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	231
From 75 to 84	105
85 and over	24
Less than 65	57

Hypertension	57
High Cholesterol	40
Stroke	4
Ischemic Heart Disease	20
Depression	17
Chronic Kidney Disease	25
Asthma	9
Osteoperosis	10
Atrial Fibrilation	6
Heart Failure	14
Chronic Obstructive Pulmonary Disease	11
Diabetes	21
Dementia	4
Cancer	75

biological response modifier (BRM) therapy	53
chemotherapy	53
doctor visit	190
lab tests	195
minimally invasive procedures	53

**Gender**
Male	104
Female	182

**Ethnicity**
Non-Hispanic White	146
Black	0
Hispanic	114
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	140
From 75 to 84	0
85 and over	0
Less than 65	70

Hypertension	62
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	29
Depression	31
Chronic Kidney Disease	38
Asthma	14
Osteoperosis	8
Atrial Fibrilation	0
Heart Failure	15
Chronic Obstructive Pulmonary Disease	13
Diabetes	29
Dementia	0
Cancer	66

biological response modifier (BRM) therapy	120
blood draw	20
chemotherapy	120
doctor visit	269
lab tests	219
minimally invasive procedures	142

**Gender**
Male	92
Female	132

**Ethnicity**
Non-Hispanic White	121
Black	0
Hispanic	87
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	126
From 75 to 84	0
85 and over	0
Less than 65	47

Hypertension	65
High Cholesterol	42
Stroke	0
Ischemic Heart Disease	29
Depression	31
Chronic Kidney Disease	39
Asthma	14
Osteoperosis	7
Atrial Fibrilation	7
Heart Failure	15
Chronic Obstructive Pulmonary Disease	14
Diabetes	35
Dementia	10
Cancer	63

biological response modifier (BRM) therapy	107
chemotherapy	107
doctor visit	209
hospital care	24
inpatient care	24
lab tests	154
minimally invasive procedures	129

**Gender**
Male	84
Female	158

**Ethnicity**
Non-Hispanic White	137
Black	0
Hispanic	87
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	123
From 75 to 84	50
85 and over	11
Less than 65	58

Hypertension	65
High Cholesterol	38
Stroke	6
Ischemic Heart Disease	29
Depression	32
Chronic Kidney Disease	40
Asthma	7
Osteoperosis	9
Atrial Fibrilation	6
Heart Failure	14
Chronic Obstructive Pulmonary Disease	16
Diabetes	30
Dementia	10
Cancer	64

biological response modifier (BRM) therapy	158
chemotherapy	158
doctor visit	206
minimally invasive procedures	180
port flush	19

**Gender**
Male	73
Female	168

**Ethnicity**
Non-Hispanic White	127
Black	0
Hispanic	90
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	130
From 75 to 84	57
85 and over	0
Less than 65	0

Hypertension	66
High Cholesterol	45
Stroke	0
Ischemic Heart Disease	32
Depression	29
Chronic Kidney Disease	41
Asthma	7
Osteoperosis	7
Atrial Fibrilation	5
Heart Failure	14
Chronic Obstructive Pulmonary Disease	13
Diabetes	32
Dementia	10
Cancer	61

biological response modifier (BRM) therapy	133
chemotherapy	133
doctor visit	275
hormone therapy	15
minimally invasive procedures	166
port flush	24

**Gender**
Male	100
Female	173

**Ethnicity**
Non-Hispanic White	168
Black	13
Hispanic	81
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	163
From 75 to 84	66
85 and over	14
Less than 65	30

Hypertension	66
High Cholesterol	51
Stroke	0
Ischemic Heart Disease	30
Depression	23
Chronic Kidney Disease	43
Asthma	8
Osteoperosis	5
Atrial Fibrilation	8
Heart Failure	19
Chronic Obstructive Pulmonary Disease	14
Diabetes	32
Dementia	9
Cancer	68

biological response modifier (BRM) therapy	211
chemotherapy	211
doctor visit	281
hormone therapy	17
minimally invasive procedures	183
port flush	27
urologic procedures	52

**Gender**
Male	116
Female	225

**Ethnicity**
Non-Hispanic White	200
Black	16
Hispanic	103
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	191
From 75 to 84	92
85 and over	17
Less than 65	41

Hypertension	62
High Cholesterol	50
Stroke	4
Ischemic Heart Disease	30
Depression	23
Chronic Kidney Disease	38
Asthma	8
Osteoperosis	6
Atrial Fibrilation	6
Heart Failure	19
Chronic Obstructive Pulmonary Disease	16
Diabetes	31
Dementia	7
Cancer	64

biological response modifier (BRM) therapy	429
chemotherapy	429
doctor visit	913
hormone therapy	18
minimally invasive procedures	445
port flush	63

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Virginia Kaklamani, MD for Medicare patients.

The highest averages for the top procedures that Dr. Virginia Kaklamani, MD treated as a medical oncologist in San Antonio, TX were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

biological response modifier (BRM) therapy	166
blood draw	60
chemotherapy	166
doctor visit	359
hormone therapy	30
hospital care	70
inpatient care	70
lab tests	194
minimally invasive procedures	185
urologic procedures	52

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Virginia Kaklamani, MD.

**Gender**
Female	176
Male	66

**Ethnicity**
Black / African American	20
Asian / Pacific Islander	0
Non-Hispanic White	142
Native American / Alaskan Native	0
Hispanic	63
Other	0

**Age**
85 and over	9
75 to 84	45
Less than 65	36
65 to 74	133

Average of Total of Conditions of Medicare patients treated by Dr. Virginia Kaklamani, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Virginia Kaklamani, MD treated were cancer, hypertension, high cholesterol and chronic kidney disease.

Hypertension	50
High Cholesterol	34
Stroke	1
Ischemic Heart Disease	22
Depression	20
Chronic Kidney Disease	28
Asthma	7
Osteoporosis	6
Heart Failure	12
Chronic Obstructive Pulmonary Disease	10
Diabetes	23
Atrial Fibrillation	4
Cancer	53
Dementia	5

Education & Training

Dr. Virginia Kaklamani, MD graduated from University of Athens Faculty of Medicine. She completed residency at Newton-Wellesley Hospital. She is certified by the American Board of Internal Medicine/Medical Oncology and has a state license in Illinois.

Medical School: University of Athens Faculty of Medicine

Residency: Newton-Wellesley Hospital (1999)

Board Certification: American Board of Internal Medicine/Medical Oncology

Licensed In: Illinois

Affiliations & Hospitals

Dr. Virginia Kaklamani, MD is associated with these hospitals and organizations:

Baptist Health System

University Health

Baptist Hospital

UT Health San Antonio

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Virginia Kaklamani, MD appears to accept the following insurance providers: Superior Health Plan, BlueCross BlueShield of Texas, Humana PPO, Coventry HMO, WellCare Medicare Advantage, Private Healthcare Systems (PHCS), Prime Health, Medicare Advantage, MultiPlan, Coventry PPO, Coventry Workers' Compensation, Three Rivers, Humana HMO, Aetna, United Healthcare, Medicaid, Humana, Molina Healthcare, HealthSmart, Aetna EPO, First Health, Aetna PPO, Aetna HMO, WellPoint, Oscar - Commercial Exchange, Interlink - Transplant, Point Comfort Underwriters (PCU) - Refugee Medical Assistance, Provider Network of America (PNOA) - Commercial, Insurance Accepted, OptumHealth - Transplant ONLY, Scott & White Health Plan - HMO, Gonzaba Medical Group - Transplant ONLY, Universal Benefits Consortium - Brokerage Firm (School Districts), University of Incarnate Word (Gilsbar) - Direct Employer, Scott & White Health Plan - PPO, Tokio Marine - Transplant, 90 Degree Benefits - Commercial, 6 Degrees - Transplant, LifeTrac - Transplant, Point Comfort Underwriters (PCU) - Unaccompanied Children, Ancira Enterprises - Direct Employer, Velocity National Provider Network - Wrap Network, Independent Medical Systems (IMS) - PPO, Entrust - TPA, EBSO - TPA and Velocity National Provider Network - Commercial PPO.

Insurance Accepted by Provider includes:

According to our sources, Dr. Virginia Kaklamani, MD accepts the following insurance providers:

Superior Health Plan

BlueCross BlueShield of Texas

Humana PPO

Coventry HMO

WellCare Medicare Advantage

Private Healthcare Systems (PHCS)

Prime Health

Medicare Advantage

MultiPlan

Coventry PPO

Coventry Workers' Compensation

Three Rivers

Humana HMO

Aetna

United Healthcare

Medicaid

Humana

Molina Healthcare

HealthSmart

Aetna EPO

First Health

Aetna PPO

Aetna HMO

WellPoint

Oscar - Commercial Exchange

Interlink - Transplant

Point Comfort Underwriters (PCU) - Refugee Medical Assistance

Provider Network of America (PNOA) - Commercial

Insurance Accepted

OptumHealth - Transplant ONLY

Scott & White Health Plan - HMO

Gonzaba Medical Group - Transplant ONLY

Universal Benefits Consortium - Brokerage Firm (School Districts)

University of Incarnate Word (Gilsbar) - Direct Employer

Scott & White Health Plan - PPO

Tokio Marine - Transplant

90 Degree Benefits - Commercial

6 Degrees - Transplant

LifeTrac - Transplant

Point Comfort Underwriters (PCU) - Unaccompanied Children

Ancira Enterprises - Direct Employer

Velocity National Provider Network - Wrap Network

Independent Medical Systems (IMS) - PPO

Entrust - TPA

EBSO - TPA

Velocity National Provider Network - Commercial PPO

Show More

Ratings & Reviews

Dr. Virginia Kaklamani, MD has an exceptional overall rating with an average of 4.8 out of 5 stars based on 296 ratings. We collect ratings and reviews of Dr. Virginia Kaklamani, MD from all over the web to help you find the right in San Antonio, TX.

4.8

Overall Rating

(296 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Virginia Kaklamani, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Gilead Sciences, Inc.	$149,058 Trodelvy $145,872	$3,185
Pfizer Inc.	$145,350 IBRANCE $90,369	TALZENNA $48,431	$6,550
Genentech USA, Inc.	$121,746 Perjeta $45,319	Kadcyla $39,554	Phesgo $35,209	$1,664
Celgene Corporation	$87,639 Abraxane $82,005	$5,634
EISAI INC.	$60,969 Halaven $60,919	Lenvima $42	AKYNZEO $8
Other	$333,048 Nerlynx $50,935	Enhertu $43,506	PIQRAY $24,454	TUKYSA $23,450	Orserdu $20,838	Other $169,864

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$587,508
Consulting Fee	$236,572
Travel and Lodging	$50,169
Food and Beverage	$11,993
Honoraria	$8,350
Other	$3,218

Research Payments

Dr. Virginia Kaklamani, MD has received 627 research payments totaling $5,612,672.

Biography

Dr. Virginia Kaklamani is an adult oncology, medical oncology, and hematology (blood disorders) specialist. She graduated from the University of Athens Faculty of Medicine and then she performed her residency at Newton-Wellesley Hospital and a hospital affiliated with Tufts University. Her clinical interests include anemia. On average, patients gave Dr. Kaklamani a rating of 5.0 stars (out of 5). She seems to honor Aetna EPO, Blue California, HealthSmart, and more. Dr. Kaklamani is conversant in Greek. She is affiliated with the University Health, UT Health San Antonio, and Baptist Health System. Dr. Kaklamani has an open panel in San Antonio, TX according to UT Health San Antonio.